Buy research peptides across Europe

Europe's largest biotech market with leading research universities.

Berlin · Munich · 5–14 days →

Global pharmaceutical innovation hub with INSERM and Pasteur networks.

Paris · Lyon · 5–14 days →

Fast-growing biotech market — served by our global fulfilment network.

67+ cities · 5–14 days →

Mediterranean pharmaceutical powerhouse with strong CRO infrastructure.

Rome · Milan · 5–14 days →

Dense biotech corridor and Europe's pharmaceutical logistics gateway.

Amsterdam · 5–14 days →

Home to Europe's densest biotech cluster around Leuven and Ghent.

Brussels · 5–14 days →

Iberian biotech market with Lisbon and Porto university research hubs.

Lisbon · 5–14 days →

Central European research infrastructure with Vienna life-science cluster.

Vienna · 5–14 days →

Global pharma headquarters — Roche, Novartis and ETH Zürich ecosystem.

Zürich · 5–14 days →

Europe's biopharma manufacturing hub for nine of the world's top ten.

Dublin · 5–14 days →

Scandinavian pharmaceutical leader with strong Karolinska research base.

Stockholm · 5–14 days →

Home of Novo Nordisk and world-leading peptide research institutions.

Copenhagen · 5–14 days →

Scandinavian biomedical research with strong public funding.

Oslo · 5–14 days →

Nordic innovation leader with cutting-edge biomedical research.

Helsinki · 5–14 days →

Central Europe's fastest-growing biotech market.

Warsaw · 5–14 days →

Competitive biotech research with strong university infrastructure.

Prague · 5–14 days →

Long pharmaceutical tradition with competitive research costs.

Budapest · 5–14 days →

Growing pharmaceutical research and manufacturing footprint.

Athens · 5–14 days →

Emerging Eastern European market with strong research talent.

Bucharest · 5–14 days →

EU member state with growing biotech investment.

Zagreb · 5–14 days →

Long pharmaceutical manufacturing tradition with competitive costs.

Sofia · 5–14 days →

Central European eurozone member with growing biotech research.

Bratislava · 5–14 days →

Compact eurozone nation with strong Krka/Lek pharmaceutical sector.

Ljubljana · 5–14 days →

Europe's most digitally advanced nation with biotech research base.

Tallinn · 5–14 days →

Baltic pharmaceutical industry with competitive life-sciences research.

Riga · 5–14 days →

Baltic state with strong laser-tech and biotech research sectors.

Vilnius · 5–14 days →

Affluent eurozone nation with growing life-sciences research.

Luxembourg · 5–14 days →

Nordic island renowned for genetic and biomedical research.

Reykjavík · 5–14 days →

Mediterranean pharmaceutical manufacturing base in the EU framework.

Valletta · 5–14 days →

Eastern Mediterranean university research and healthcare hub.

Nicosia · 5–14 days →

Balkan research hub with strong Belgrade university and genetics institutes.

Belgrade · 5–14 days →

Deep biomedical research base across Kyiv, Lviv and Kharkiv.

Kyiv · 5–14 days →

Major pharmaceutical manufacturing and university research sector.

Istanbul · 5–14 days →

Growing Adriatic research and clinical market.

Tirana · 5–14 days →

Established university medicine across Sarajevo and Banja Luka.

Sarajevo · 5–14 days →

Compact Adriatic research and private-clinic market.

Podgorica · 5–14 days →

Skopje-anchored genetics and biotechnology research base.

Skopje · 5–14 days →

Developing research market with strong medical university base.

Chișinău · 5–14 days →

Pyrenean longevity and private-clinic market.

Andorra la Vella · 5–14 days →

Concentrated longevity, sports-medicine and aesthetic clinical sector.

Monte-Carlo · 5–14 days →

EEA microstate inside the Swiss-Austrian research corridor.

Vaduz · 5–14 days →

Enclave research market alongside the Emilia-Romagna corridor.

San Marino · 5–14 days →

Metabolic

Semaglutide

Metabolic

Tirzepatide

Metabolic

Retatrutide

Metabolic

Liraglutide

Metabolic

Cagrilintide

Metabolic

Survodutide

Growth Hormone

Ipamorelin

Growth Hormone

CJC-1295 (no DAC)